GC33923
Brivudine
Also listed as Brivudine (Bromovinyldeoxyuridine)
Brivudine (Bromovinyldeoxyuridine) is a thymidine analogue with antiviral activity, indicated for the early treatment of acute herpes zoster
ChemicalCAS69304-47-8MW333.14FormulaC11H13BrN2O5
- CAS number
- 69304-47-8
- Molecular weight
- 333.14
- Formula
- C11H13BrN2O5
- Solubility
- DMSO ： ≥ 330 mg/mL (990·57 mM)
- InChIKey
- ODZBBRURCPAEIQ-PIXDULNESA-N
- Catalogue number
- GC33923
- Brand
- GLPBIO
Computed properties PubChem CID 446727 · XLogP -0.4 · TPSA 99.1 Ų · H-bond donors 3
- XLogP
- -0.4
- TPSA
- 99.1 Ų
- H-bond donors
- 3
- H-bond acceptors
- 5
- Rotatable bonds
- 3
- Heavy atoms
- 19
SMILES C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)/C=C/Br)CO)O
Computed descriptors from PubChem (CID 446727), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il